MDMA THERAPY

Magic truffles, also known as sclerotia, raise many questions. Are they mushrooms? Why are they available in the Netherlands (under certain conditions) while magic mushrooms are prohibited? And what do they mean in the context of trauma and therapy? In this article, we clearly explain what sclerotia are, how they work, the general implications of Dutch law, and the relevant risks and points of attention, with a particular focus on harm reduction and the topic of trauma. Throughout this process, we distinguish between scientific knowledge, practical experience, and what we simply do not (yet) know for certain.

What are sclerotia (magic truffles)?

In mycology, “sclerotium” refers to a compact clump of mycelium (fungal threads) that some fungi form to survive during unfavorable conditions, such as drought or a lack of nutrients. You can think of it as an underground storehouse: the sclerotium stores nutrients and a little moisture, and can regrow later when conditions become more favorable.

The magic truffles sold in smart shops are sclerotia of certain psilocybin-producing species. They contain psychoactive substances such as psilocybin and psilocin. These are the same main substances found in psilocybin mushrooms. The difference lies primarily in the part of the organism being sold: for truffles, it is the sclerotium; for magic mushrooms, it is the fruiting body (the “mushroom” with stem and cap).

Truffles versus magic mushrooms: what exactly is the difference?

Biologically, truffles and magic mushrooms come from the same broader family of psilocybin-producing fungi, but they are different “forms” of that fungus. Magic mushrooms are fruiting bodies that disperse spores. Sclerotia, on the other hand, are designed to survive. In user experience, the effects often resemble each other, but they can differ in intensity and predictability.

An important practical difference is that the active content can vary per batch. This can be related to strain, cultivation conditions, freshness, and storage. As a result, dosing is less precise than with standardized (pharmaceutical) psilocybin, such as that used in research.

What substances does it contain and how does it work in the body?

The best-known active substance is psilocybin. In the body, psilocybin is converted into psilocin. Psilocin primarily affects the serotonin system, which can lead to changes in perception, emotions, thoughts, and the perception of time. For example, people report more intense colors and patterns, a different sense of meaning, and heightened emotional sensitivity.

The effects typically begin within 30 to 60 minutes after ingestion and often last for several hours. The overall “aftermath” can persist longer, for example in the form of fatigue or a feeling of sensitivity. Please note: these are general patterns based on information and anecdotal evidence. How it plays out for an individual can vary greatly.

Legislation in the Netherlands: why are truffles (often) available?

In the Netherlands, psilocybin mushrooms have been banned from sale since December 1, 2008. In practice, Sclerotia fall into a different category and are available as long as they are sold fresh. At the same time, it is important to realize that legislation contains details and can change, and that processing methods such as drying or extraction are described as not permitted in many sources. Anyone wishing to delve into this would do well to consult current, reliable information and be cautious with assumptions.

What stands out in practice: availability via smartshops causes some people to view truffles as “safe” or “mild”. This is not automatically justified. “Legally available” is not the same as risk-free, certainly not when set, setting, and mental resilience are not properly taken into account.

Risks, side effects and “bad trips” (harm reduction)

Truffles can provide pleasant, meaningful experiences, but also difficult ones. Anxiety, panic, confusion, and paranoia are frequently mentioned as possible acute effects, as are nausea or vomiting. In an unfamiliar environment, under stress, or when combined with alcohol or other substances, risks generally increase.

A “bad trip” is not an official medical term, but is often used for an overwhelming experience involving fear or loss of control. This can be intense in itself. Additionally, indirect risks can arise from clumsy choices during intoxication, such as getting lost, falling, or ending up in traffic. Harm reduction is therefore not about romanticizing or demonizing the substance, but about minimizing avoidable harm.

Practical harm-reduction points that frequently recur in information:

1) Pay attention to set & setting: a quiet, familiar place and sufficient time without obligations.

2) Ensure you have sober supervision: someone you trust and who does not use.

3) Start low: especially with limited experience or when feeling nervous.

4) Do not combine: alcohol and other substances make effects less predictable.

5) No traffic or hazardous activities: reaction time and assessment may change.

Truffles, therapy, and trauma: what do we know and what don't we know?

The keyword “trauma” frequently recurs in conversations about psychedelics. Scientific research into psilocybin focuses on depression, anxiety, and addiction, among other things, and there is broader interest in how altered states of consciousness can aid in emotion processing. At the same time, it is important to maintain a clear distinction: research is conducted under strict conditions, involving screening, supervision, and controlled dosing. This is different from self-experimentation or a commercial setting.

With trauma, extra nuance is needed. Some people describe that psychedelic experiences help them look at painful memories or patterns from a distance, or feel emotions that were previously shut off. Others, however, experience flashbacks, panic, or dysregulation. It is impossible to predict with certainty beforehand which way it will go. Factors such as preparation, resilience, the presence of dissociation, and the quality of guidance can likely make a significant difference, but there are limits to what we can verify without knowing your personal situation.

Important: this article is not individual advice and makes no medical claims. If someone has trauma-related symptoms, it is wise not to look solely at the remedy, but especially at context, guidance, contraindications, and aftercare. “More openness” is not always better, certainly not if someone has little stability or support (yet).

Guided sessions and responsibility: where does MDMA fit into this story?

On mdmatherapie.nl, the relationship between MDMA and therapy and trauma is frequently discussed. It is important to note that MDMA sessions can currently only be discussed within the framework of scientific research or in practice via harm reduction. This means that the content and quality of guidance in practice can vary significantly, and that you should be extra critical regarding screening, transparency, and the boundaries of what someone can promise.

Truffles and MDMA are different substances with different effect profiles and different experiences. Yet one principle remains the same: an intense experience can only have a meaningful impact if attention is paid to preparation, guidance, and integration. Integration means, for example: what happened, what touched you, which insights are helpful, and how do you translate that into daily steps without overwhelming yourself?

If you are considering a session: questions to help with careful consideration

Anyone considering a guided session (regardless of the substance) can benefit from down-to-earth, practical questions. For example: What does the intake look like? Are contraindications and safety agreements addressed? Is there room for aftercare and integration? And what happens if you become anxious or panic?

If you are exploring the possibilities and guidance broadly, you can read more on the website about psilocybin therapy and the way in which set, setting, and harm reduction are viewed in practice. Anyone wishing to subsequently determine whether a referral is appropriate within the available options can do so via Sign up for MDMA session. View this as a starting point for information and consideration, not as a promise of an outcome.

Conclusion

Sclerotia, or magic truffles, are not “magic mushrooms” in the strict biological sense, but a survival form of certain psilocybin-producing fungi. They contain similar active compounds and can cause profound changes in perception and emotion. This same depth also means that risks are real, especially with unprepared use, an unsafe setting, or vulnerability due to trauma. Anyone wishing to explore something therapeutically with truffles or other substances would do well to remain critical, prioritize harm reduction, and clearly distinguish between scientific research, anecdotal evidence, and what is or is not responsible in practice.